Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$152.8M
-20.6% from 2023
Prescriptions
2.3M
$67.26 per claim
Patients
850K
275,466 prescribers
Total spending, 2024
$152.9M
$179.67 per patient
Medicare prescription drug plans paid $152.8M for Ventolin Hfa in 2024, for 2,271,640 prescriptions and refills to 850,437 patients (down 20.6% from 2023). The average cost per claim was $67.26.
California had the highest Medicare cost for Ventolin Hfa in 2024: $10.6M for 164,984 claims, followed by Florida ($10.1M).
Jorge Sanchez-Masiques, pulmonary disease in Miami, FL, had the highest Medicare cost for Ventolin Hfa in 2024: 1,935 claims costing $105K.
Ventolin Hfa is made by GSK plc (GSK), listed in the Medicare spending data as Glaxosmithkline.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Jorge Sanchez-Masiques Miami, FL | Pulmonary Disease | 1,935 | 542 | $105K |
| Reuven Moshenyat Brooklyn, NY | Pulmonary Disease | 1,278 | 309 | $74K |
| Irina Zolotarevskaya |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 272,377 | 2,297,312 | 836,950 | $170.3M |
| 2023 | 296,222 | 2,627,491 | 955,936 | $192.4M |
| 2024 | 275,466 | 2,271,640 | 850,437 | $152.8M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Pulmonary Disease |
| 1,133 |
| 180 |
| $69K |
| Odette L Campbell Plano, TX | Internal Medicine | 473 | 172 | $46K |
| Juan C Acevedo-Crespo Coral Gables, FL | Pulmonary Disease | 812 | 312 | $44K |
| Ihab M Deebajah Garden City, MI | Pulmonary Disease | 671 | 181 | $42K |
| Rudolf Khusid Yardley, PA | Pulmonary Disease | 729 | 106 | $42K |
| Rafael A Martinez Tampa, FL | Pulmonary Disease | 534 | 169 | $34K |
| Miranda D Withers Somerset, KY | Nurse Practitioner | 511 | 155 | $34K |
| Bao Q Nguyen Stockton, CA | Family Practice | 515 | 76 | $33K |
| Zulfiqar Ahmed Glendale, CA | Pulmonary Disease | 554 | 125 | $32K |
| Jay Jay M Joseph Las Vegas, NV | Nurse Practitioner | 578 | 84 | $32K |
| Sixto R Caro Brooklyn, NY | Internal Medicine | 229 | 68 | $31K |
| Ladly Abraham Conway, AR | Pulmonary Disease | 458 | 164 | $31K |
| Michael M Dao Garden Grove, CA | Internal Medicine | 533 | 144 | $30K |
| Hoang T Le Fountain Valley, CA | Pulmonary Disease | 512 | 133 | $30K |
| Nataliya Sevastyanova Springfield, MA | Nurse Practitioner | 413 | 107 | $30K |
| Shelley D Stockton Bruce Somerset, KY | Nurse Practitioner | 473 | 175 | $30K |
| Nancy M Potvin Pittsfield, MA | Nurse Practitioner | 355 | 97 | $29K |
| Rhona A Fingal Detroit, MI | Internal Medicine | 545 | 105 | $28K |
| Anargyros T Skaliotis North Dartmouth, MA | Physician Assistant | 450 | 91 | $28K |
| Hazen H Tuck Jr. Janesville, WI | Pulmonary Disease | 321 | 83 | $28K |
| Yoel Brito Miami, FL | Pulmonary Disease | 504 | 143 | $28K |
| Morgan G Miller Rocky Mount, NC | Nurse Practitioner | 368 | 122 | $27K |
| Hamid Rehman Rochester, MN | Pulmonary Disease | 295 | 109 | $26K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Glaxosmithkline GSK | 2,272,575 | $152.9M |